methyl 5-cyano-5-(4-chlorophenyl)-2-oxocyclohexanecarboxylate | 56326-94-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 5-cyano-5-(4-chlorophenyl)-2-oxocyclohexanecarboxylate
• 英文别名: 2-carbomethoxy-4-(p-chlorophenyl)-4-cyanocyclohexanone；2-Carbomethoxy-4-(p-chlorphenyl)-4-cyano-cyclohexanon；methyl 5-(4-chlorophenyl)-5-cyano-2-oxocyclohexane-1-carboxylate
• CAS: 56326-94-4
• 化学式: C₁₅H₁₄ClNO₃
• 分子量: 291.734
• InChiKey: UAHBIGYKUJRYPQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  67.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 5-cyano-5-(4-chlorophenyl)-2-oxocyclohexanecarboxylate 在 硫酸 作用下， 以 正己烷 、 5-氰基-2-氧代-5-苯基环己烷羧酸甲酯 、 溶剂黄146 、 乙酸乙酯 为溶剂， 以75%的产率得到4-氰-4-苯基环己酮
  参考文献：
  名称：

  4-Amino-4-phenylcyclohexanone ketal compositions and process of use

  摘要：

  一类新的4-氨基-4-芳基环己酮，它们的缩醛和酸盐已经合成，并发现对于缓解动物的疼痛很有用。它们的镇痛活性似乎是很高的，并且一些还表现出对镇痛引起的心血管、呼吸和行为抑制有用的麻醉拮抗活性。其中几种显示出混合的镇痛和麻醉拮抗活性。该类化合物的首选化合物是4-(间羟基苯基)-4-二甲氨基环己酮乙二醚缩醛，以及4-(间羟基苯基)-4-(正丁基甲基氨基)环己酮乙二醚缩醛，作为游离碱和其盐酸盐形式。描述了合成和中间体的过程。披露了单位剂量形式和治疗方法。

  公开号：

  US04065573A1
• 作为产物：
  描述：

  4-(4-氯苯基)-4-氰基庚二酸二甲酯 在 potassium tert-butylate 作用下， 生成 methyl 5-cyano-5-(4-chlorophenyl)-2-oxocyclohexanecarboxylate
  参考文献：
  名称：

  丁苯酮作为降压药。4-芳基-4-（羟甲基）环己胺的衍生物。

  摘要：

  描述了从相应的4-氰基-4-苯基环己酮-1-酮开始制备4-芳基-4-（羟甲基）环己-1-基胺的丁苯酮衍生物。两个环都有不同的取代基；对4-苯基-4-（羟甲基）环己-1-基胺的两种异构体进行了表征。与缺乏羟甲基的化合物相比，在丁苯酮上进行对氟取代的那些衍生物在大鼠中表现出降压活性，而CNS活性降低。讨论了取代对4-芳基环的影响。

  DOI：

  10.1021/jm00240a014

文献信息

• 4-Pyrrolidino-cyclohexanone ketals
  申请人：The Upjohn Company

  公开号：US04180584A1

  公开（公告）日：1979-12-25

  A class of new 4-amino-4-arylcyclohexanones, their ketals, and acid addition salts have been synthesized and found to be useful for relieving pain in animals. Their analgesic activity appears to be of high order, and in addition some exhibit narcotic antagonist activity that is useful in modifying the cardiovascular, respiratory, and behavioral depression caused by other analgesics. Several show mixed analgesic and narcotic antagonist activity. Preferred compounds of the class are 4-(m-hydroxyphenyl)-4-dimethylaminocyclohexanone ethylene ketal, and 4-(m-hydroxyphenyl)-4-(n-butylmethylamino)cyclohexanone ethylene ketal as free bases and as their hydrochloride salts. Processes for snythesis and intermediates are described. Unit dosage forms and therapeutic treatments are disclosed.

  一类新的4-氨基-4-芳基环己酮、它们的缩酮和酸加成盐已被合成并发现对缓解动物疼痛有用。它们的镇痛活性似乎是高级别的，另外一些表现出麻醉拮抗活性，有助于改变其他镇痛剂引起的心血管、呼吸和行为抑制。几种显示出混合的镇痛和麻醉拮抗活性。该类化合物的首选物是4-（间羟基苯基）-4-二甲氨基环己酮乙二醇缩酮和4-（间羟基苯基）-4-（正丁基甲基氨基）环己酮乙二醇缩酮，作为自由碱和它们的盐酸盐。描述了合成和中间体的过程。揭示了单元剂量形式和治疗方法。
• 4-Arylcyclohexylamines
  申请人：The Upjohn Company

  公开号：US03979444A1

  公开（公告）日：1976-09-07

  The invention relates to novel 4-hydroxymethyl(acyloxymethyl and methyl)-4-arylcyclohexylamines embraced by the formula ##SPC1## Wherein Ar is an aromatic ring selected from the group consisting of phenyl and naphthyl, each of which has from zero through three substituents independently selected from the group consisting of fluorine, chlorine, bromine, lower alkyl of one through three carbon atoms, lower alkoxy of one through three carbon atoms, and lower alkylthio of one through three carbon atoms; Z is selected from the group consisting of hydrogen, hydroxy and lower acyloxy of one through four carbon atoms; .about. is a generic expression denoting cis and trans stereoconfiguration and mixtures thereof, with the proviso that when the stereoconfiguration of the linkage connecting the cyclohexane ring and CH.sub.2 Z is cis to the amino group, the linkage connecting the cyclohexane and Ar rings is trans, and vice versa; R.sup.1 is selected from the group consisting of hydrogen and lower alkyl of one through three carbon atoms; R.sup.2 is selected from the group consisting of hydrogen, lower alkyl of one through three carbon atoms, ##EQU1## WHEREIN N IS 2 THROUGH 5 AND Ar has the same meaning as above; R.sup.1 and R.sup.2 taken together with --N< is a saturated heterocyclic amino radical selected from the group consisting of unsubstituted and substituted pyrrolidino, piperidino, hexamethylenimino, morpholino and piperazino; and pharmacologically acceptable acid addition salts thereof. It also relates to intermediates and processes for the preparation of the aforesaid novel compounds (I) and novel derivatives thereof. The administration to humans and animals of the novel compounds (I) depresses their central nervous systems and lowers their blood pressures.

  本发明涉及一种新型的4-羟甲基（酰氧甲基和甲基）-4-芳基环己胺，其公式为##SPC1##其中Ar是从苯基和萘基选择的芳香环，每个环都有从0到3个取自氟、氯、溴、1至3个碳原子的低级烷基、1至3个碳原子的低级烷氧基和1至3个碳原子的低级烷基硫基的官能团自由置换；Z选择自氢、羟基和1至4个碳原子的低级酰氧基的官能团自由置换；∼是表示顺式和反式立体构型及其混合物的通用表达式，但当连接环己烷环和CH.sub.2 Z的立体构型为顺式时，连接环己烷环和Ar环的立体构型为反式，反之亦然；R.sup.1选择自氢和1至3个碳原子的低级烷基的官能团自由置换；R.sup.2选择自氢、1至3个碳原子的低级烷基、## EQU1##其中N为2至5，Ar具有与上述相同的含义；R.sup.1和R.sup.2与--N <一起取代为选自未取代和取代的吡咯烷基、哌啶烷基、六亚甲基亚胺基、吗啉基和哌嗪基的饱和杂环氨基基团；以及其药学上可接受的酸加盐。本发明还涉及上述新型化合物（I）及其新型衍生物的中间体和制备方法。将新型化合物（I）用于人类和动物可以抑制其中枢神经系统并降低其血压。
• Analgetic compounds, compositions and process of treatment
  申请人：The Upjohn Company

  公开号：US04447454A1

  公开（公告）日：1984-05-08

  Novel compounds of the formula: ##STR1## wherein R.sub.1 is a variable consisting of hydrogen, alkyl of from 1 to 8 carbon atoms, CH.sub.2 -alkenyl wherein alkenyl is from 2 to 4 carbon atoms, inclusive, cycloalkyl of from 3 to 6 carbon atoms, inclusive, cycloalkylmethyl of from 3 to 6 carbon atoms, inclusive; R.sub.2 is a variable consisting of hydrogen, alkyl of from 1 to 8 carbon atoms, inclusive, with the proviso that R.sub.1 and R.sub.2 cannot both be hydrogen at the same time; Y is a variable consisting of alkyl of from 1 to 4 carbon atoms, inclusive, halogen, trifluoromethyl, hydroxy, alkanoyloxy from 2 to 5 carbon atoms, inclusive, alkoxy of from 1 to 4 carbon atoms, inclusive, cycloalkyloxy of from 3 to 6 carbon atoms, inclusive, benzyloxy; m is an integer 0, 1, 2; R.sub.5 is a variable consisting of hydrogen and alkyl of from 1 to 4 carbon atoms, inclusive; R.sub.3 is a variable consisting of alkyl of from 1 to 4 carbon atoms, inclusive; R.sub.4 is a variable consisting of alkyl of from 1 to 4 carbon atoms, inclusive, CH.sub.2 -alkenyl wherein alkenyl is of from 2 to 4 carbon atoms, inclusive, and arylalkyl wherein alkyl is from 1 to 4 carbon atoms, inclusive, and aryl is ##STR2## wherein Y' is CF.sub.3, halogen, alkyl of 1 to 4 carbon atoms, inclusive, and alkoxy of from 1 to 4 carbon atoms, inclusive; and R.sub.3 and R.sub.4 when taken together with the nitrogen atom to which they are attached can form saturated heterocycles of from 5 to 7 ring members, a second hetero atom of said ring can be oxygen or nitrogen, e.g., morpholine, piperazine, and said heterocycles can be monosubstituted having a total of up to 9 carbon atoms, with the proviso that when ##STR3## is pyrrolidinyl, then m=1, 2, having analgetic activity in humans and animals are prepared in unit dosage forms. The compositions are useful in relieving pain by administering orally, parenterally, and rectally to humans and animals.

  该专利描述了一种新的化合物，其化学式为：##STR1## 其中R.sub.1是变量，包括氢、1到8个碳原子的烷基、CH.sub.2-烯丙基（烯丙基中含有2到4个碳原子）、3到6个碳原子的环烷基、3到6个碳原子的环烷基甲基；R.sub.2是变量，包括氢、1到8个碳原子的烷基，但R.sub.1和R.sub.2不能同时为氢；Y是变量，包括1到4个碳原子的烷基、卤素、三氟甲基、羟基、2到5个碳原子的烷酰氧基、1到4个碳原子的烷氧基、3到6个碳原子的环烷氧基、苄氧基；m是整数0、1、2；R.sub.5是变量，包括氢和1到4个碳原子的烷基；R.sub.3是变量，包括1到4个碳原子的烷基；R.sub.4是变量，包括1到4个碳原子的烷基、2到4个碳原子的CH.sub.2-烯丙基、1到4个碳原子的芳基烷基，其中芳基是##STR2## Y'是CF.sub.3、卤素、1到4个碳原子的烷基和1到4个碳原子的烷氧基；当R.sub.3和R.sub.4与它们连接的氮原子一起形成5到7个环成员的饱和杂环时，该环的第二个杂原子可以是氧或氮，例如吗啡啶、哌嗪，该杂环可以是单取代的，总碳原子数最多为9个，但当##STR3## 是吡咯烷基时，m=1、2，该化合物在人类和动物中具有镇痛作用，并以单位剂量形式制备。该组合物可以通过口服、注射和直肠给药来缓解疼痛。
• LEDNICER, D.
  作者：LEDNICER, D.

  DOI：——

  日期：——
• US3979444A
  申请人：——

  公开号：US3979444A

  公开（公告）日：1976-09-07